- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04130490
The Heidelberg Engineering ANTERION Anterior Segment Cornea and IOL Precision and Agreement Study
April 26, 2024 updated by: Heidelberg Engineering GmbH
This is a prospective clinical study that will be conducted at one clinical site located in the United States to assess anterior segment parameters with the ANTERION
Study Overview
Status
Completed
Intervention / Treatment
Study Type
Observational
Enrollment (Actual)
176
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
New York
-
New York, New York, United States, 10036
- State University of New York College of Optometry
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
Yes
Sampling Method
Probability Sample
Study Population
Eyes with normal anterior segment and crystalline lens; eyes with cataract of grade 1.5 or higher; eyes with abnormal corneal shape; eyes with status post-keratorefractive surgery and eyes without a crystalline lens
Description
Inclusion Criteria:
- Age 22 years or older
- Able and willing to undergo the test procedures, sign informed consent, and follow instructions
- Able to fixate
With the following eye pathology status for the individual eye population:
- A. Eye with normal anterior segment and crystalline lens
- B. Eye with a cataract of grade 1.5 or higher
- C. Eye with abnormal corneal shape
- D. Eye with status post-keratorefractive surgery
- E. Eye without a crystalline lens
Exclusion Criteria:
- Subjects which were enrolled in the B-2018-1 clinical study
- Active infection or inflammation in the study eye
- Insufficient tear film or corneal reflex
- Physical inability to be properly positioned at the study devices or eye exam equipment
- Rigid contact lens wear 2 weeks prior to imaging
- Soft lenses worn within one hour prior to imaging
With the following eye pathology status for the individual eye population:
- A. Eye meets eligibility criteria for eye populations B, C, D or E
- B. Eye meets eligibility criteria for eye populations C,D or E
- C. Eye meets eligibility criteria for eye populations D or E
- E. Eye with abnormal corneal shape (except status post-keratorefractive surgery)
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
|---|---|
|
Eye with normal Anterior Segment
3 repeat measurements on each of the 3 investigational and reference devices
|
3 repeat measurements performed with two of the ANTERION acquisition types and 3 repeat measurements performed with 2 acquisition types of the references devices
|
|
Eye with cataract
3 repeat measurements on each of the 3 investigational and reference devices
|
3 repeat measurements performed with two of the ANTERION acquisition types and 3 repeat measurements performed with 2 acquisition types of the references devices
|
|
Eye with corneal abnormality
3 repeat measurements on each of the 3 investigational and reference devices
|
3 repeat measurements performed with two of the ANTERION acquisition types and 3 repeat measurements performed with 2 acquisition types of the references devices
|
|
Eye with status post-keratorefractive surgery
3 repeat measurements on each of the 3 investigational and reference devices
|
3 repeat measurements performed with two of the ANTERION acquisition types and 3 repeat measurements performed with 2 acquisition types of the references devices
|
|
Eye without a crystalline lens
3 repeat measurements on each of the 3 investigational and reference devices
|
3 repeat measurements performed with two of the ANTERION acquisition types and 3 repeat measurements performed with 2 acquisition types of the references devices
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Precision and Agreement 1
Time Frame: 1 day
|
Reproducibility, repeatability and agreement of Anterior Corneal Topography parameters (3mm ring) of ANTERION and the reference device
|
1 day
|
|
Precision and Agreement 2
Time Frame: 1 day
|
Reproducibility, repeatability and agreement of Anterior Corneal Topography parameters (6mm zone) of ANTERION and the reference device
|
1 day
|
|
Precision and Agreement 3
Time Frame: 1 day
|
Reproducibility, repeatability and agreement of Posterior Corneal Topography parameters (3mm ring) of ANTERION and the reference device
|
1 day
|
|
Precision and Agreement 4
Time Frame: 1 day
|
Reproducibility, repeatability and agreement of Posterior Corneal Topography parameters (6mm zone) of ANTERION and the reference device
|
1 day
|
|
Precision and Agreement 5
Time Frame: 1 day
|
Reproducibility, repeatability and agreement of Cornea Thickness (µm) of ANTERION and the reference device
|
1 day
|
|
Precision and Agreement 6
Time Frame: 1 day
|
Reproducibility, repeatability and agreement of Lens Thickness, ACD, Pupil Diameter, White-to-White, Axial Length (mm) of ANTERION and the reference device
|
1 day
|
|
Precision and Agreement 7
Time Frame: 1 day
|
Reproducibility, repeatability and agreement of Anterior Chamber Volume (mm^3) of ANTERION and the reference device
|
1 day
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Adverse Events Rate
Time Frame: 1 day
|
Adverse events found during the clinical study
|
1 day
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Principal Investigator: Mitchell Dul, State University of New York College of Optometry
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
October 11, 2019
Primary Completion (Actual)
October 30, 2023
Study Completion (Actual)
December 30, 2023
Study Registration Dates
First Submitted
October 11, 2019
First Submitted That Met QC Criteria
October 15, 2019
First Posted (Actual)
October 17, 2019
Study Record Updates
Last Update Posted (Actual)
April 30, 2024
Last Update Submitted That Met QC Criteria
April 26, 2024
Last Verified
April 1, 2024
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- B-2018-5
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
Yes
product manufactured in and exported from the U.S.
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.